Bio-Rad Laboratories | BIO - Beneficio Bruto En Ventas





Beneficio Bruto En Ventas Cambio Fecha
Abbott USD 6.65B 787M 2026-06
Agilent USD 1.04B 52M 2026-06
Becton, Dickinson and Co. USD 2.32B 161M 2026-06
Bio Techne USD 222.15M 13.86M 2026-06
Bio-Rad Laboratories USD 345.8M 36.4M 2026-06
Bruker USD 416M 36.2M 2026-06
Charles River Laboratories USD 348.78M 69.47M 2026-06
Danaher USD 3.61B 20M 2026-06
General Electric Aerospace USD 4.46B 220M 2026-06
Illumina USD 770M 49M 2026-06
IQVIA Holdings USD 1.44B 368M 2026-06
Laboratory Of America USD 1.11B 98.2M 2026-06
Merck USD 12.09B 1.24B 2026-03
Mettler Toledo International USD 555.82M 119.62M 2026-03
Myriad Genetics USD 146.8M 3M 2025-12
OraSure Technologies USD 11.34M 435K 2025-12
Pacific Biosciences Of California USD 15.74M 601K 2025-12
Quest Diagnostics USD 906M 33M 2026-03
Repligen USD 110.04M 1.75M 2026-06
Revvity USD 416.87M 29.21M 2026-06
Roche Holding CHF 22.69B 600M 2026-06
Siemens EUR 7.68B 51M 2026-03
Standard Biotools USD 11.31M 74K 2026-03
Thermo Fisher Scientific USD 4.49B 146M 2026-03
Tosoh JPY 67.57B 10.89B 2025-09
Waters USD 490M 52M 2026-06